Beta-2 Adrenergic Receptor Polymorphic Variants: An Endotype of Salt Sensitive Hypertension (Beta2AR).

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-50
SponsorBrigham and Women's Hospital

About this trial

All living things are made of building blocks called cells. Genes are the part of cells that contain the instructions which determine important things about you, like your height or hair color, and affect your health. DNA is the material in the cells that makes up your genes and your particular make-up is call your genotype. Changes or differences in a gene (your genotype) may affect your chances of developing a particular disease, or how a person responds to a particular drug. Your genes are passed down from your parents and then passed on to your children. Different forms of certain genes in your body, for example, the B2AR gene, can increase your blood pressure. The form of the gene that could raise your blood pressure is called the risk allele or risk genotype.

Taking too much salt in your food or drink also can increase your blood pressure. In this research study we want to determine if different forms of the B2AR gene and the level of salt intake act together to cause high blood pressure.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Ages 18-50 years; HTN as defined by the primary physician; on ≤ two anti-hypertensives; normal renal, liver, metabolic, electrolyte, CBC, and thyroid tests.

Disqualifiers

Pregnancy; renal, neurologic, and cardiac diseases other than HTN; diabetes; secondary HTN as assessed by history, physical examination, screening blood and urine tests; any drug therapy, except for anti-hypertensives and replacement thyroid medication; and no oral contraceptives/implants/ERT within 2 years of study.

Trial design

Design model

Crossover

Treatments tested in this trial

  • low sodium diet

    Other intervention

    Low Sodium Diet

  • high sodium diet

    Other intervention

    High Sodium Diet

  • renal plasma flow

    Procedure/Surgery

    renal blood flow response to diet and angiotensin II by diplotype

  • SIEA collection

    Procedure/Surgery

    Vasoreactivity response by diplotype

Treatment groups

110 Participants
are divided into 2 treatment groups
Group A: Low SaltExperimental treatment 2 interventions
Group B: High SaltExperimental treatment 3 interventions

Trial outcomes

Primary outcomes

1

Differences in systolic SSBP between the diplotypes

Differences in systolic SSBP between the diplotypes

Time frame
Two weeks

Secondary outcomes

1

Differences in B2AR expression levels by diplotype

Differences in B2AR expression levels by diplotype

Time frame
Two weeks
2

Sodium excretion response to acute sodium load by diplotype

Sodium excretion response to acute sodium load by diplotype

Time frame
Two weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Brigham and Women's Hospital

Lead sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

This trial is not recruiting at the moment. You can still explore other options: